& Inge, T
The authors compare multiple senolytic strategies including FOXO4-DRI, dasatinib plus quercetin, navitoclax, and fisetin, evaluating mechanisms of action, selectivity profiles, and safety considerations for each approach
Studies in women with both obesity and PCOS show that GLP-1 medications can have positive effects on menstrual cycles, ovulation, and fertility
Table of Contents The link between obesity and osteoarthritis How GLP-1 therapies may affect joint health What recent clinical trials show Are benefits caused only by weight loss
Microdosing refers to the use of subtherapeutic or lower-than-standard doses of GLP-1 receptor agonists, such as semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro, Zepbound), with the aim of minimizing side effects while maintaining therapeutic benefits